Godavari Drugs Ltd
₹88.67
(-2.23)%
Fri, 06 Feb 2026, 01:38 am
Health Technology
Pharmaceuticals: Major
24.5K1 Day
0 (0%)
No Result Found
Summary
Market Cap
66.77
Net Profit
4.38
P/B
1.52
Sector P/E
39.83
P/E
15.03
EV/EBITDA
9.98
Debt/Equity (Industry)
0.16
Interest Cover (Industry)
22.44
ROCE (Industry)
20.01
RONW (Industry)
16.77
ROE
10.64
ROCE
10.06
Debt/Equity
1.48
EPS (TTM)
5.78
Dividend Yield
0
Book Value
57.56
Interest Cover
2.19
Analysis
all
- Godavari Drugs is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Godavari Drugs is profitable, therefore cash runway is not a concern.
- Godavari Drugs is profitable, therefore cash runway is not a concern.
- Debt is covered by short term assets, assets are 2.3x debt.
- Godavari Drugs's cash and other short term assets cover its long term commitments.
- Unable to evaluate Godavari Drugs's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Godavari Drugs's dividend against the top 25% market benchmark as the company has not reported any payouts.
- Debt is not well covered by operating cash flow (15.1%, less than 20% of total debt).
- The level of debt compared to net worth has increased over the past 5 years (31.5% vs 129.5% today).
- Interest payments on debt are not well covered by earnings (EBIT is 2x annual interest expense, ideally 3x coverage).
Shareholding
| Shareholders | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 | DEC 2024 |
|---|---|---|---|---|---|
| Promoters | 52.61 | 52.61 | 52.63 | 52.63 | 52.63 |
| FII | 0 | 0 | 0 | 0 | 0 |
| DII | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 |
| Public | 46.89 | 46.89 | 46.87 | 46.87 | 46.87 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 155.22 | 121.87 | 104.98 | 88.52 | 71.63 | 55.17 | 21.82 |
| Fibonacci | 121.87 | 109.13 | 101.26 | 88.52 | 75.78 | 67.91 | 55.17 |
| Camarilla | 97.27 | 94.21 | 91.16 | 88.52 | 85.04 | 81.99 | 78.93 |
Pivots Level: Classic
R3
+66.70
155.22
R2
+33.35
121.87
R1
+16.47
104.98
S1
-16.88
71.63
S2
-33.35
55.17
S3
-66.70
21.82
Moving Average
Period
Value
10-EMA
89.36
20-EMA
88.44
30-EMA
87.10
50-EMA
85.29
100-EMA
84.54
200-EMA
87.42
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 21 Jan 2026 | egm | ||
| 14 Nov 2025 | board-meetings | Quarterly Results | |
| 04 Aug 2025 | agm | ||
| 30 May 2024 | agm | ||
| 21 Jul 2023 | agm | ||
| 25 Apr 2022 | agm | ||
| 23 Jul 2021 | agm |
Peer Comparison
Godavari Drugs Ltd
Torrent Pharmaceuticals Ltd
Dr Reddys Laboratories Ltd
Sun Pharmaceutical Industries Ltd
Divis Laboratories Ltd
Cipla Ltd
About Godavari Drugs Ltd
Godavari Drugs engaged in the business of manufacture of Active Pharmaceutical Ingredients (API) and its intermediates through its manufacturing facility at Nanded, Maharashtra, India.
Industry
Pharmaceuticals - Indian - Bulk Drugs
Founded
1987
Headquarters
CEO
Ghanshyam Jaju
Employees
Contact
Website
http://www.godavaridrugs.com
info@godavaridrugs.com
Phone
91-40-27849700/27844557
Location
Mayfair 1-8-303-34, Sardar Patel Road, Secunderabad, Andhra Pradesh, 500003
godavari drugs ltd History
| Year | History |
|---|---|
| 1987 |
|
| 1988 |
|
| 1989 |
|
| 1992 |
|
| 2012 |
|
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800